Mirova Merck & Co., Inc. Transaction History

Mirova

$568 Million
Q4 2024

A detailed history of Mirova transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mirova holds 3,255 shares of MRK stock, worth $306,035. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,255

Previous 6,987 53.41%

Holding current value

$306,035

Previous $793,000 59.27%

% of portfolio

0.06%

Previous 0.14%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$96.31 - $114.76 $359,428 - $428,284	-3,732 Reduced 53.41%	3,255 $323,000
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $644,998 - $692,721	5,210 Added 293.19%	6,987 $864,000
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $10,819 - $11,774	-108 Reduced 5.73%	1,777 $193,000
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $517,632 - $574,851	-5,028 Reduced 72.73%	1,885 $194,000
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $930,244 - $1.01 Million	-8,565 Reduced 55.34%	6,913 $797,000
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $21,205 - $23,661	-206 Reduced 1.31%	15,478 $1.65 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $140,253 - $179,824	1,604 Added 11.39%	15,684 $1.74 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $204,647 - $229,898	-2,421 Reduced 14.67%	14,080 $1.21 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $144,103 - $163,348	1,726 Added 11.68%	16,501 $1.5 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $17,936 - $20,105	-244 Reduced 1.62%	14,775 $1.21 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $1.63 Million - $2.04 Million	-22,558 Reduced 60.03%	15,019 $1.15 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $244,715 - $269,125	3,414 Added 9.99%	37,577 $2.82 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $106,449 - $117,743	1,514 Added 4.64%	34,163 $2.66 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $323,159 - $380,649	4,693 Added 16.79%	32,649 $2.52 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $1.83 Million - $2.03 Million	25,489 Added 1033.2%	27,956 $2.29 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $51,884 - $58,811	-709 Reduced 22.32%	2,467 $205,000
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $4,577 - $5,208	-65 Reduced 2.01%	3,176 $246,000
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $84,268 - $116,800	-1,330 Reduced 29.1%	3,241 $249,000
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $134,213 - $151,444	1,730 Added 60.89%	4,571 $416,000
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $19,476 - $21,230	256 Added 9.9%	2,841 $239,000
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $53,646 - $61,186	771 Added 42.5%	2,585 $215,000
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $118,345 - $137,337	1,814 New	1,814 $139,000

Others Institutions Holding MRK

# of Institutions

3,972

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $238B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

News

Stay updated on Mirova with notifications on news.

Account